86 related articles for article (PubMed ID: 14565862)
1. Microencapsulation of tumor necrosis factor oligomers: a new approach to proinflammatory cytokine inhibition.
Oettinger C; D'Souza M
J Interferon Cytokine Res; 2003 Sep; 23(9):533-43. PubMed ID: 14565862
[TBL] [Abstract][Full Text] [Related]
2. Prevention of lethality and suppression of proinflammatory cytokines in experimental septic shock by microencapsulated CNI-1493.
D'Souza MJ; Oettinger CW; Milton GV; Tracey KJ
J Interferon Cytokine Res; 1999 Oct; 19(10):1125-33. PubMed ID: 10547152
[TBL] [Abstract][Full Text] [Related]
3. Synergism in survival to endotoxic shock in rats given microencapsulated CNI-1493 and antisense oligomers to NF-kappaB.
Oettinger CW; D'Souza MJ
J Microencapsul; 2010; 27(4):372-6. PubMed ID: 20515262
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental septic shock with microencapsulated antisense oligomers to NF-kappaB.
D'Souza MJ; Jin Z; Oettinger CW
J Interferon Cytokine Res; 2005 Jun; 25(6):311-20. PubMed ID: 15957954
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of pro-inflammatory cytokine suppression and survival by microencapsulated dexamethasone in the treatment of experimental sepsis.
Uddin MN; Siddiq A; Oettinger CW; D'Souza MJ
J Drug Target; 2011 Nov; 19(9):752-60. PubMed ID: 21913870
[TBL] [Abstract][Full Text] [Related]
6. The effect of intracellular delivery of catalase and antisense oligonucleotides to NF-kappaB using albumin microcapsules in the endotoxic shock model.
Siwale RC; Oettinger CW; Addo R; Siddig A; D'Souza MJ
J Drug Target; 2009 Nov; 17(9):701-9. PubMed ID: 19845486
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory cytokine inhibition in the primate using microencapsulated antisense oligomers to NF-kappaB.
Oettinger CW; D'souza MJ; Akhavein N; Peer GT; Taylor FB; Kinasewitz GT
J Microencapsul; 2007 Jun; 24(4):337-48. PubMed ID: 17497387
[TBL] [Abstract][Full Text] [Related]
8. Microencapsulated drug delivery: a new approach to pro-inflammatory cytokine inhibition.
Oettinger CW; D'Souza MJ
J Microencapsul; 2012; 29(5):455-62. PubMed ID: 22348221
[TBL] [Abstract][Full Text] [Related]
9. Microspheres containing neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 beta protect rats from Staphylococcus aureus-induced peritonitis.
D'Souza M; Oettinger CW; Milton GV
J Interferon Cytokine Res; 2000 Oct; 20(10):907-13. PubMed ID: 11054279
[TBL] [Abstract][Full Text] [Related]
10. [The effect of transmembrane- and secreted-tumor necrosis factor-alpha on shock liver].
Yin B; Li Z; Yu S; Jiang X; Feng W; Xu Y
Zhonghua Bing Li Xue Za Zhi; 2002 Dec; 31(6):534-7. PubMed ID: 12622907
[TBL] [Abstract][Full Text] [Related]
11. Effect of TNF-alpha antisense oligomers on cytokine production by primary murine alveolar macrophages.
Taylor MF; Weller DD; Kobzik L
Antisense Nucleic Acid Drug Dev; 1998 Jun; 8(3):199-205. PubMed ID: 9669657
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of a morpholino antisense oligomer directed against tumor necrosis factor-alpha.
Qin G; Taylor M; Ning YY; Iversen P; Kobzik L
Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):11-6. PubMed ID: 10726656
[TBL] [Abstract][Full Text] [Related]
13. Targeting macrophages with microspheres containing cytokine-neutralizing antibodies prevents lethality in gram-negative peritonitis.
Oettinger CW; D'Souza M; Milton GV
J Interferon Cytokine Res; 1999 Jan; 19(1):33-40. PubMed ID: 10048766
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages.
Pearse DD; Pereira FC; Stolyarova A; Barakat DJ; Bunge MB
Eur J Neurosci; 2004 Dec; 20(12):3387-96. PubMed ID: 15610171
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumour necrosis factor and reversal of endotoxin-induced shock by U-83836E, a 'second generation' lazaroid in rats.
Altavilla D; Squadrito F; Serrano M; Campo GM; Squadrito G; Arlotta M; Urna G; Sardella A; Saitta A; Caputi AP
Br J Pharmacol; 1998 Jul; 124(6):1293-9. PubMed ID: 9720803
[TBL] [Abstract][Full Text] [Related]
16. Comparison of efficacy of antisense oligomers directed toward TNF-alpha in helper T and macrophage cell lines.
Taylor MF; Paulauskis JD; Weller DD; Kobzik L
Cytokine; 1997 Sep; 9(9):672-81. PubMed ID: 9325016
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides.
Ponnappa BC; Israel Y; Aini M; Zhou F; Russ R; Cao QN; Hu Y; Rubin R
Biochem Pharmacol; 2005 Feb; 69(4):569-77. PubMed ID: 15670576
[TBL] [Abstract][Full Text] [Related]
18. The effect of intracellular antioxidant delivery (catalase) on hydrogen peroxide and proinflammatory cytokine synthesis: a new therapeutic horizon.
Siwale RC; Yeboah GK; Addo R; Oettinger CW; D'Souza MJ
J Drug Target; 2009 Nov; 17(9):710-8. PubMed ID: 19845487
[TBL] [Abstract][Full Text] [Related]
19. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of a Nuphar lutea partially purified leaf extract in murine models of septic shock.
Ozer J; Levi T; Golan-Goldhirsh A; Gopas J
J Ethnopharmacol; 2015 Feb; 161():86-91. PubMed ID: 25490314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
